Latent sites of Epstein-Barr virus infection. 1993

W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
Department of Pathology, Queen Mary Hospital Compound, University of Hong Kong.

Epstein-Barr virus (EBV) has been detected in a wide spectrum of tumors. This study investigates the detection rate of EBV-DNA by Southern blot hybridization analysis (SOBH) and polymerase chain reaction (PCR) in different tissues from persons without apparent EBV-related diseases. Of 20 tonsillectomy specimens studied, SOBH indicated positivity for EBV-DNA in 1 case, and PCR indicated positivity in 10. In autopsies performed on patients with no apparent evidence of EBV-related diseases, the viral DNA was only detected by PCR in the following: parotid gland (7/15), submandibular gland (8/20), nasopharynx (8/10), tonsil (8/10), larynx (5/6), lung (5/9), cervical lymph node (7/10), mediastinal lymph node (7/10), abdominal lymph node (4/10), spleen (6/10), thyroid (5/10), liver (1/10), pancreas (1/4), kidney (4/10), uterine cervix (1/4), ovary (1/5) and testis (1/3). These results provide a baseline for interpreting the role of EBV in carcinogenesis.

UI MeSH Term Description Entries
D008297 Male Males
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
July 1997, Reviews in medical virology,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
March 2006, Nihon rinsho. Japanese journal of clinical medicine,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
September 2001, The British journal of dermatology,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
October 1994, The American journal of pathology,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
January 2015, Experimental & molecular medicine,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
January 1975, IARC scientific publications,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
February 2020, Nature communications,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
September 2016, Annual review of virology,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
May 2016, Leukemia & lymphoma,
W Y Cheung, and A C Chan, and S L Loke, and G Srivastava, and S Pittaluga, and L Y Lim, and F C Ho
April 1999, The British journal of dermatology,
Copied contents to your clipboard!